A Study of Uveitis in Children <18 Years of Age

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1Since this study is focused on understanding how common different types of uveitis are in children under 18, rather than testing a new treatment, what would my child actually gain from participating — and would it change their current care in any way?
2. 2This trial is in the 'NA' phase, which suggests it's an observational or registry-style study rather than a treatment trial — can you help me understand exactly what my child would be asked to do, and whether there are any risks or burdens involved in participating?
3. 3Because the study is just measuring the frequency of uveitis subtypes and not offering a new therapy, should we focus first on making sure my child has the best available standard treatment, and could participation in this study run alongside that?
4. 4Given that this study is actively recruiting children under 18 with uveitis, does my child's specific type of uveitis — whether it's related to an autoimmune condition like juvenile idiopathic arthritis or something else — make them a particularly relevant or useful participant?
5. 5Are there other clinical trials studying actual treatments for pediatric uveitis that might also be worth considering alongside or instead of this observational study?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.